LATEST NEWS
2020
- November - MLM Biologics receives approval for ISO-13485 certification at its new facility
- July - MLM Biologics introduces new bio-ConneKt® size for treating large wounds
- January - Chandra Nataraj, Ph.D. founder of MLM Biologics, presents to the Arthroscopy & Regenerative Medicine Cadaver Lab in Jonesboro, GA
- January - bio-ConneKt® Wound Matrix establishes new monthly usage level
2018
- November - Surgeon training in the Middle East. Surgeons from 5 countries in attendance
- October - MLM Biologics introduces two new preferred bio-ConneKt® sizes for out-patient use
- September - bio-ConneKt® is placed on the national SAC-VA IDIQ biologics contract (#36C10G18DO127)
- July - MLM Biologics partners with Pediatric Surgery Centers in the Tampa area to assist in managing patients undergoing difficult to heal pilonidal cyst surgery
2016
- January - received first Medicare Administrative Contractor territory approvals covering 12 states
2015
- December - second major investment from private entity into MLM Biologics
- November - CMS establishes Q4161 as a stand-alone HCPCS code for bio-ConneKt® Wound Matrix to become effective January 1, 2016
- October - Major investment from private entity into MLM Biologics
- March - Chandra Nataraj founder of MLM Biologics, presents at the Gainesville Area Innovation Network (GAIN) meeting
- February - Received ISO 13485 Certification for our facility in Alachua, FL
2014
- December - Submitted to CMS for product specific HCPCS code
- October - First bio-ConneKt® Wound Matrix product applied
- July - Received 510(k) clearance from the FDA for bio-ConneKt® Wound Matrix
2013
- January - The USPTO issued a Notice of Allowance for the trademark application of bio-ConneKt® Wound Matrix
2012
- October - MLM Biologics is incorporated as a Delaware corporation